Navigation Links
Nutraceutical Reports Fiscal 2008 Q1 Results
Date:1/31/2008

p> Amortization of intangible assets 167 46

Income from operations 5,518 5,556

Interest and other (income)/expense, net 380 144

Income before provision for income taxes 5,138 5,412

Provision for income taxes 1,927 2,057

Net income $3,211 $3,355

Net income per common share

Basic $0.29 $0.30

Diluted 0.28 0.30

Weighted average common shares outstanding

Basic 11,123,792 11,015,967

Diluted 11,270,089 11,212,285

NUTRACEUTICAL INTERNATIONAL CORPORATION

EBITDA SCHEDULE

(unaudited; dollars in thousands)

Three months ended December 31,

2007 2006

Net income $3,211 $3,355

Provision for income taxes 1,927 2,057

Interest and other (income)/expense, net (1) 380 144

Depreciation and amortization 1,312 1,101

EBITDA $6,830 $6,657

(1) Includes amortization of deferred financing fees and losses associated

with fixed asset disposals.


'/>"/>
SOURCE Nutraceutical International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
2. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
3. Nutraceutical Reports 2007 Fiscal Year End Results
4. New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs
5. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced
6. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
7. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
8. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
9. Encision Reports Third Fiscal Quarter Results
10. Zimmer Reports Fourth Quarter and 2007 Financial Results
11. Amylin Pharmaceuticals Reports 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...assessing traditional risk factors, experts say ,...wo molecular signs -- or "biomarkers" -- of inflam...to assess a person,s risk of stroke, new research ... adding these markers does not change things much,...logist at the Methodist DeBakey Heart & Vascul...
(Date:1/8/2009)...ption business continues to drive overall performa...- Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI ),...n and e-prescribing, today offered a corporate upd... , "We ended the year on a high note in our Emai...ders for the year in the fourth quarter," said Spu...
(Date:1/8/2009)... A proposal by the State...ors Children,s Home has prompted the 125,000-membe...its annual Mid-Winter conference January 10-12, 20...s, nearly unanimous opposition to the proposal. ,... $50,000 in direct and in-kind support to the home...
(Date:1/8/2009)... Missile Strikes , , NEW YORK, Jan. 8 /PRNewsw... and the Jewish Federations of North America today...arian and social needs in southern Israel, part of...rity with Israelis during the current conflict wit...the Gaza Strip. , , The funds will enhance pro...
Breaking Medicine News(10 mins):Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2
...or people suffering diabetic retinopathy. The trea...leviating the effects of diabetic retinopathy,// w...etes. In the initial stages, retinopathy does not...apable of progressing gradually to cause the blood...
...t a single counseling intervention that includes a... contexts may have an impact on HIV// prevention b...blished in the April 15th edition of the Journal o...ble evidence exists that alcohol use contributes t...
...tective shield in early childhood. But new researc...ugh to adolescence and adulthood. Child// fed on b... on bottle feed. The earlier study had pressed t... that breast feed was necessary to reduce childhoo...
...at took place last week at the Virginia Tech Many ...re asking the congressmen to formulate some// meas...f program, to identify and treat the mentally ill,...aw that would permit the university to inform the ...
Other Medicine News:Health News:Brief Intervention on HIV and Alcohol Risk Encourages Safer Sex 2Health News:Brief Intervention on HIV and Alcohol Risk Encourages Safer Sex 3Health News:Measures Needed to Avert Another Bloodbath 2
(Date:1/6/2009)...re-FirstCall/ -- , - Early Renewal of the A...er 2011 , - Expansion of the Scope of the C...thalmology , - Revised Commercial Terms and... Third Party , ExonHit Therapeutics (Alte...its existing drug discovery collaboration with All...
(Date:1/5/2009)...FirstCall/ -- Micromet, Inc.,(Nasdaq: MITI ), a...ietary,antibodies for the treatment of cancer, in...utlook on key events anticipated for the year 2009... on its research and development,programs at the ...: Update on several preclinical BiTE antibodies at...
(Date:1/3/2009)...Ill., Jan. 2 Magnetic r...viding an increasing number of clinical benefits w...to an article in the January 2009 issue of the Jou...ns ( http://www.jaaos.org/ ). It is predicted tha...l developments will allow MRI to provide even more...
(Date:12/29/2008)...ewswire/ -- The winner of the 2008 Award for Excel...oday by Dr. Peter G. Goldschmidt, President and Fo... The winner of the annual award was the Univers... its best practice " IND Regulatory and Monitoring...human subjects protection, 2) improved data qualit...
Breaking Medicine Technology:ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 32008 Human Research Protection Award Recipients Announced 2New nanostructured thin film shows promise for efficient solar energy conversion 2511 1New nanostructured thin film shows promise for efficient solar energy conversion 2511 2New nanostructured thin film shows promise for efficient solar energy conversion 2511 3Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 1Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 2Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 3Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 4Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 5Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 6AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA 9280 1AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA 9280 2Round Table Family Charities Raises 24350 000 for Childrens Miracle Network 9276 1Round Table Family Charities Raises 24350 000 for Childrens Miracle Network 9276 2
...-- Shire plc,announced today the positive results ...acine extended release (GXR,previously referred t...onist. These data from two short-term phase,III pl...II,open-label studies, presented at the 2007 Ameri...demonstrated that GXR,significantly improved all c...
...onoclonal Antibody,Targeting Interleukin-9 (IL-9);...-9 Inhibition in Developing Potential Asthma,Thera...FirstCall/ --,MedImmune, Inc. today announced the ...within the company,s inflammatory,disease pipeline...ies with its monoclonal antibody (MAb) targeting I...
Other Medicine Technology:Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
The Proteineer suite integrates powerful mass spectrometers with robotics and bioinformatics to deliver maximum productivity in high-throughput proteomics.
The ProteomeLab PA 800 resolves and quantifies proteins by their isoelectric point and molecular weight, generates high-resolution peptide maps and carbohydrate profiles and provides front-end separa
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110.
Medicine Products: